News Releases
-
Jul. 21 2026
Restore Vision and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership Read More
-
May. 01 2026
Restore Vision Announces First-in-Human Clinical Interim Results for RV-001, a GPCR-Based Optogenetic Gene Therapy Read More
-
Apr. 15 2026
Restore Vision Secures JPY 1.3 Billion in Pre-Series B Financing, Bringing Total Funding to More Than JPY 5.8 Billion Including Grants Read More